• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Breast cancer: current and future endocrine therapies.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Palmieri, C
    Patten, D
    Januszewski, A
    Zucchini, Giorgia
    Howell, Sacha J
    Affiliation
    1The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, Liverpool L69 3GA, UK
    Issue Date
    2014-01-25
    
    Metadata
    Show full item record
    Abstract
    Endocrine therapy forms a central modality in the treatment of estrogen receptor positive breast cancer. The routine use of 5 years of adjuvant tamoxifen has improved survival rates for early breast cancer, and more recently has evolved in the postmenopausal setting to include aromatase inhibitors. The optimal duration of adjuvant endocrine therapy remains an active area of clinical study with recent data supporting 10 years rather than 5 years of adjuvant tamoxifen. However, endocrine therapy is limited by the development of resistance, this can occur by a number of possible mechanisms and numerous studies have been performed which combine endocrine therapy with agents that modulate these mechanisms with the aim of preventing or delaying the emergence of resistance. Recent trial data regarding the combination of the mammalian target of rapamycin (mTOR) inhibitor, everolimus with endocrine therapy have resulted in a redefinition of the clinical treatment pathway in the metastatic setting. This review details the current endocrine therapy utilized in both early and advanced disease, as well as exploring potential new targets which modulate pathways of resistance, as well as agents which aim to modulate adrenal derived steroidogenic hormones.
    Citation
    Breast cancer: current and future endocrine therapies. 2014, 382 (1):695-723 Mol Cell Endocrinol
    Journal
    Molecular and Cellular Endocrinology
    URI
    http://hdl.handle.net/10541/314906
    DOI
    10.1016/j.mce.2013.08.001
    PubMed ID
    23933149
    Type
    Article
    Language
    en
    ISSN
    1872-8057
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.mce.2013.08.001
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Endocrine therapy and other targeted therapies for metastatic breast cancer.
    • Authors: Hussain SA, Palmer DH, Moon S, Rea DW
    • Issue date: 2004 Dec
    • Managing postmenopausal women with hormone receptor-positive advanced breast cancer who progress on endocrine therapies with inhibitors of the PI3K pathway.
    • Authors: Brufsky AM
    • Issue date: 2014 Jul-Aug
    • A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancer.
    • Authors: Jerusalem G, Bachelot T, Barrios C, Neven P, Di Leo A, Janni W, de Boer R
    • Issue date: 2015 Feb
    • Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
    • Authors: Jordan VC, Brodie AM
    • Issue date: 2007 Jan
    • The curability of breast cancer and the treatment of advanced disease.
    • Authors: Guarneri V, Conte PF
    • Issue date: 2004 Jun
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.